This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (195) Neurology and Neurosciences (103) Safety and Error Prevention in Health (148) Wearable Devices and Sensors (570)

Published on in Vol 10, No 10 (2021): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29695, first published .
A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study

Authors of this article:

Fatima Jamali 1 Author Orcid Image ;   Mayis Aldughmi 2 Author Orcid Image ;   Mohammad W Khasawneh 1 Author Orcid Image ;   Said Dahbour 3, 4 Author Orcid Image ;   Alaa A Salameh 1 Author Orcid Image ;   Abdalla Awidi 1, 5 Author Orcid Image
Article Authors Cited by Tweetations Metrics
Fatima Jamali 1, PhD;  Mayis Aldughmi 2, PhD;  Mohammad W Khasawneh 1, MD;  Said Dahbour 3, 4, MD;  Alaa A Salameh 1, MSc, PT;  Abdalla Awidi 1, 5, MD

1 Cell Therapy Center, University of Jordan , Amman , JO

2 Department of Physiotherapy, School of Rehabilitation Sciences, University of Jordan, Amman , JO

3 Medical Faculty, University of Jordan , Amman , JO

4 Neurology Division, Jordan University Hospital , Amman , JO

5 Hematology Department, Jordan University Hospital , Amman , JO

Corresponding Author: